ArticleSurgery today2009

TSU68, an antiangiogenic receptor tyrosine kinase inhibitor, induces tumor vascular normalization in a human cancer xenograft nude mouse model.

Manabu Ohta et al.PubMed ↗Publisher ↗

No numbers read from the abstract.